CD44v6 expression is a novel predictive marker of therapy response and poor prognosis in gastric cancer patients
C. Pereira, D. Ferreira, C. Lemos, D. Martins, N. Mendes, D. Almeida, P. Granja, F. Carneiro, R. Almeida, G. M. Almeida, C. Oliveira
This study identifies CD44v6 expression as a predictor of therapy response and poor prognosis in gastric cancer patients, showing higher expression correlates with worse outcomes and benefit from chemotherapy.
bioRxiv · Nov 30, 2018 · PreprintCancer Biology